Progesterone receptor isoform ratio: a breast cancer prognostic and predictive factor for antiprogestin responsiveness

PA Rojas, M May, GR Sequeira, A Elia… - JNCI: Journal of the …, 2017 - academic.oup.com
Background: Compelling evidence shows that progestins regulate breast cancer growth.
Using preclinical models, we demonstrated that antiprogestins are inhibitory when the level …

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

PA Rojas, M May, GR Sequeira… - Journal of the …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Compelling evidence shows that progestins regulate breast cancer growth.
Using preclinical models, we demonstrated that antiprogestins are inhibitory when the level …

Progesterone receptor isoform ratio: a breast cancer prognostic and predictive factor for antiprogestin responsiveness

PA Rojas, M May, GR Sequeira, AM Elia, M Alvarez… - 2017 - lareferencia.info
Compelling evidence shows that progestins regulate breast cancer growth. Using preclinical
models, we demonstrated that antiprogestins are inhibitory when the level of progesterone …

[PDF][PDF] Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

PA Rojas, M May, GR Sequeira, A Elia, M Alvarez… - 2017 - academia.edu
Background: Compelling evidence shows that progestins regulate breast cancer growth.
Using preclinical models, we demonstrated that antiprogestins are inhibitory when the level …

[PDF][PDF] Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

PA Rojas, M May, GR Sequeira, A Elia, M Alvarez… - 2017 - unclineberger.org
Background: Compelling evidence shows that progestins regulate breast cancer growth.
Using preclinical models, we demonstrated that antiprogestins are inhibitory when the level …

[PDF][PDF] Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

PA Rojas, M May, GR Sequeira, A Elia, M Alvarez… - 2017 - researchgate.net
Background: Compelling evidence shows that progestins regulate breast cancer growth.
Using preclinical models, we demonstrated that antiprogestins are inhibitory when the level …

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.

PA Rojas, M May, GR Sequeira, A Elia… - Journal of the …, 2017 - europepmc.org
Background: Compelling evidence shows that progestins regulate breast cancer growth.
Using preclinical models, we demonstrated that antiprogestins are inhibitory when the level …

[PDF][PDF] Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

PA Rojas, M May, GR Sequeira, A Elia, M Alvarez… - 2017 - core.ac.uk
Background: Compelling evidence shows that progestins regulate breast cancer growth.
Using preclinical models, we demonstrated that antiprogestins are inhibitory when the level …

Progesterone receptor isoform ratio: a breast cancer prognostic and predictive factor for antiprogestin responsiveness

PA Rojas, M May, GR Sequeira, AM Elia… - 2017 - notablesdelaciencia.conicet.gov.ar
Compelling evidence shows that progestins regulate breast cancer growth. Using preclinical
models, we demonstrated that antiprogestins are inhibitory when the level of progesterone …

[HTML][HTML] Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

PA Rojas, M May, GR Sequeira, A Elia… - JNCI Journal of the …, 2017 - ncbi.nlm.nih.gov
Background: Compelling evidence shows that progestins regulate breast cancer growth.
Using preclinical models, we demonstrated that antiprogestins are inhibitory when the level …